1. Home
  2. SCLXW vs PALOU Comparison

SCLXW vs PALOU Comparison

Compare SCLXW & PALOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.14

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

PALOU

Paloma Acquisition Corp I Units

N/A

Current Price

$9.97

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLXW
PALOU
Founded
N/A
N/A
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
SCLXW
PALOU
Price
$0.14
$9.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7K
61.6K
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.04
$9.96
52 Week High
$0.64
$10.01

Technical Indicators

Market Signals
Indicator
SCLXW
PALOU
Relative Strength Index (RSI) 47.49 38.71
Support Level $0.10 $9.96
Resistance Level $0.18 N/A
Average True Range (ATR) 0.02 0.02
MACD -0.00 -0.00
Stochastic Oscillator 45.16 25.00

Price Performance

Historical Comparison
SCLXW
PALOU

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About PALOU Paloma Acquisition Corp I Units

Paloma Acquisition Corp I is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: